TFF Pharmaceuticals
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2018-01-24
- Employees
- 19
- Market Cap
- -
- Website
- http://www.tffpharma.com
- Introduction
TFF Pharmaceuticals, Inc. engages in the development and commercialization of drug products based on its patented Thin Film Freezing technology platform. It focuses on the manufacture of inhaled dry powder drugs for the treatment of pulmonary diseases and conditions. The company was founded on January 24, 2018 and is headquartered in Fort Worth, TX.
Voriconazole Inhalation Powder for the Treatment of Pulmonary Aspergillosis
- Conditions
- Invasive Pulmonary AspergillosisAllergic Bronchopulmonary AspergillosisChronic Pulmonary AspergillosisAspergillus TracheobronchitisAnastomotic InfectionPulmonary Fungal Infection
- First Posted Date
- 2023-06-09
- Last Posted Date
- 2024-11-21
- Lead Sponsor
- TFF Pharmaceuticals, Inc.
- Registration Number
- NCT05897294
An Open Label Trial Evaluating the Safety, Tolerability, Efficacy and Pharmacokinetic Profile of Tacrolimus Inhalation Powder in Adult Lung Transplant Recipients
Phase 2
Terminated
- Conditions
- Lung Transplant Rejection
- Interventions
- Drug: Tacrolimus Inhalation PowderDevice: Plastiape RS00 Dry Powder inhaler device
- First Posted Date
- 2022-08-15
- Last Posted Date
- 2025-01-06
- Lead Sponsor
- TFF Pharmaceuticals, Inc.
- Target Recruit Count
- 14
- Registration Number
- NCT05501574
- Locations
- 🇦🇺
St Vincent's Hospital, Darlinghurst, New South Wales, Australia
🇦🇺The Alfred Hospital, Melbourne, Victoria, Australia
Single Ascending Dose and Multiple Ascending Dose Study of Niclosamide Inhalation Powder in Healthy Adult Subjects
- First Posted Date
- 2021-12-23
- Last Posted Date
- 2022-02-02
- Lead Sponsor
- TFF Pharmaceuticals, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT05168644
- Locations
- 🇨🇦
Altasciences, Mount Royal, Quebec, Canada
Single Ascending Dose and Multiple Ascending Dose Study of Voriconazole Inhalation Powder in Healthy Adult Subjects
- First Posted Date
- 2021-05-04
- Last Posted Date
- 2021-05-06
- Lead Sponsor
- TFF Pharmaceuticals, Inc.
- Target Recruit Count
- 65
- Registration Number
- NCT04872231
- Locations
- 🇨🇦
Cliantha Research, Mississauga, Ontario, Canada
Pharmacokinetic Profile of Voriconazole Inhalation Powder in Adult Subjects With Asthma
- First Posted Date
- 2020-10-06
- Last Posted Date
- 2021-11-18
- Lead Sponsor
- TFF Pharmaceuticals, Inc.
- Target Recruit Count
- 17
- Registration Number
- NCT04576325
- Locations
- 🇦🇺
Q-Pharm Pty Ltd (Nucleus Networks), Brisbane, Queensland, Australia
© Copyright 2025. All Rights Reserved by MedPath